European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Chimeric locked nucleic acid-deoxynucleoside phosphorothioat
Community Register of medicinal products
Community register of orphan medicinal products | GRANTED |
Product information |
Chimeric locked nucleic acid-deoxynucleoside phosphorothioate-linked oligonucleotide directed against microRNA-451
| EU orphan designation number: | EU/3/11/940
|
| Active ingredient: | Chimeric locked nucleic acid-deoxynucleoside phosphorothioate-linked oligonucleotide directed against microRNA-451 |
| Indication: | Treatment of polycythaemia vera |
| Sponsor: | Miragen Therapeutics Europe Ltd
90 High Holborn, London WC1V 6XX, United Kingdom |
Public summary of scientific opinion
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 13/01/2012 | Centralised Orphan - Designation | EMA/OD/107/11 | (2012)126 of 11/01/2012 |